Terminated PHASE4 INTERVENTIONAL 2-arm NCT00998582

Artery Elasticity After Switch From Epzicom to Truvada

Sponsor: Hennepin Healthcare Research Institute

Updated 11 times since 2017 Last updated: Oct 3, 2012 Started: Oct 31, 2009 Primary completion: Jun 30, 2011 Completion: Dec 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Low enrollment

Other terminated trials from Hennepin Healthcare Research Institute

See all terminations from Hennepin Healthcare Research Institute

Other HIV Infections trials with similar outcome

Browse all HIV Infections trials

Listed as NCT00998582, this PHASE4 trial focuses on HIV Infections and remains terminated or withdrawn. Sponsored by Hennepin Healthcare Research Institute, it has been updated 11 times since 2009, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2023 — Jul 2024 [monthly]

Terminated PHASE4
Dec 2022 — Jan 2023 [monthly]

Terminated PHASE4
Dec 2021 — Dec 2022 [monthly]

Terminated PHASE4

▶ Show 6 earlier versions

Jan 2021 — Dec 2021 [monthly]

Terminated PHASE4
Apr 2020 — Jan 2021 [monthly]

Terminated PHASE4
May 2019 — Apr 2020 [monthly]

Terminated PHASE4
Jun 2018 — May 2019 [monthly]

Terminated PHASE4
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE4
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE4

First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hennepin Healthcare Research Institute

Data source: Hennepin Healthcare Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Minneapolis, United States